The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder

Henry M. Rosevear; Andrew J. Lightfoot; Michael A. O'Donnell; Thomas S. Griffith

doi:10.1007/s10555-009-9195-6

The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder

Henry M. Rosevear, Andrew J. Lightfoot, Michael A. O'Donnell, Thomas S. Griffith

Urology

Research output: Contribution to journal › Review article › peer-review

47 Scopus citations

Abstract

Intravesical Mycobacterium bovis bacillus Calmette-Guérin (BCG) immunotherapy is a highly effective treatment for carcinoma in situ of the bladder, as well as high-risk nonmuscle invasive urothelial carcinoma of the bladder. Despite over 30 years of clinical experience with BCG, the therapy's mechanism has remained enigmatic. Observations regarding the role of neutrophils in BCG immunotherapy have led to exciting discoveries regarding the potential role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in creating the therapeutic benefit of BCG immunotherapy. In this paper, we will review the scope of the disease, highlight our understanding of the role for BCG in urothelial carcinoma of the bladder, explain the recent discoveries regarding the role of neutrophils and TRAIL in therapy, and theorize on potential future areas of research.

Original language	English (US)
Pages (from-to)	345-353
Number of pages	9
Journal	Cancer and Metastasis Reviews
Volume	28
Issue number	3-4
DOIs	https://doi.org/10.1007/s10555-009-9195-6
State	Published - 2009

Keywords

BCG
Bladder cancer
Neutrophil
TRAIL
Urothelial carcinoma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1007/s10555-009-9195-6

OpenUrl availability

Full text

Cite this

The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder. / Rosevear, Henry M.; Lightfoot, Andrew J.; O'Donnell, Michael A. et al.
In: Cancer and Metastasis Reviews, Vol. 28, No. 3-4, 2009, p. 345-353.

Research output: Contribution to journal › Review article › peer-review

@article{ca06041eaa364136a0275932ae46da4f,

title = "The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Gu{\'e}rin (BCG) immunotherapy for urothelial carcinoma of the bladder",

abstract = "Intravesical Mycobacterium bovis bacillus Calmette-Gu{\'e}rin (BCG) immunotherapy is a highly effective treatment for carcinoma in situ of the bladder, as well as high-risk nonmuscle invasive urothelial carcinoma of the bladder. Despite over 30 years of clinical experience with BCG, the therapy's mechanism has remained enigmatic. Observations regarding the role of neutrophils in BCG immunotherapy have led to exciting discoveries regarding the potential role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in creating the therapeutic benefit of BCG immunotherapy. In this paper, we will review the scope of the disease, highlight our understanding of the role for BCG in urothelial carcinoma of the bladder, explain the recent discoveries regarding the role of neutrophils and TRAIL in therapy, and theorize on potential future areas of research.",

keywords = "BCG, Bladder cancer, Neutrophil, TRAIL, Urothelial carcinoma",

author = "Rosevear, {Henry M.} and Lightfoot, {Andrew J.} and O'Donnell, {Michael A.} and Griffith, {Thomas S.}",

year = "2009",

doi = "10.1007/s10555-009-9195-6",

language = "English (US)",

volume = "28",

pages = "345--353",

journal = "Cancer and Metastasis Reviews",

issn = "0167-7659",

publisher = "Springer Netherlands",

number = "3-4",

}

TY - JOUR

T1 - The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder

AU - Rosevear, Henry M.

AU - Lightfoot, Andrew J.

AU - O'Donnell, Michael A.

AU - Griffith, Thomas S.

PY - 2009

Y1 - 2009

N2 - Intravesical Mycobacterium bovis bacillus Calmette-Guérin (BCG) immunotherapy is a highly effective treatment for carcinoma in situ of the bladder, as well as high-risk nonmuscle invasive urothelial carcinoma of the bladder. Despite over 30 years of clinical experience with BCG, the therapy's mechanism has remained enigmatic. Observations regarding the role of neutrophils in BCG immunotherapy have led to exciting discoveries regarding the potential role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in creating the therapeutic benefit of BCG immunotherapy. In this paper, we will review the scope of the disease, highlight our understanding of the role for BCG in urothelial carcinoma of the bladder, explain the recent discoveries regarding the role of neutrophils and TRAIL in therapy, and theorize on potential future areas of research.

AB - Intravesical Mycobacterium bovis bacillus Calmette-Guérin (BCG) immunotherapy is a highly effective treatment for carcinoma in situ of the bladder, as well as high-risk nonmuscle invasive urothelial carcinoma of the bladder. Despite over 30 years of clinical experience with BCG, the therapy's mechanism has remained enigmatic. Observations regarding the role of neutrophils in BCG immunotherapy have led to exciting discoveries regarding the potential role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in creating the therapeutic benefit of BCG immunotherapy. In this paper, we will review the scope of the disease, highlight our understanding of the role for BCG in urothelial carcinoma of the bladder, explain the recent discoveries regarding the role of neutrophils and TRAIL in therapy, and theorize on potential future areas of research.

KW - BCG

KW - Bladder cancer

KW - Neutrophil

KW - TRAIL

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=76649113379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76649113379&partnerID=8YFLogxK

U2 - 10.1007/s10555-009-9195-6

DO - 10.1007/s10555-009-9195-6

M3 - Review article

C2 - 19967427

AN - SCOPUS:76649113379

SN - 0167-7659

VL - 28

SP - 345

EP - 353

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

IS - 3-4

ER -

The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder

Abstract

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this